AAAAAA
Results:
1-23
|
Results: 23
Authors:
Binder, WJ
Brin, MF
Blitzer, A
Pogoda, JM
Citation: Wj. Binder et al., Botulinum toxin type A (BOTOX) for treatment of migraine, SEM CUT M S, 20(2), 2001, pp. 93-100
Authors:
Verheyden, J
Blitzer, A
Brin, MF
Citation: J. Verheyden et al., Other noncosmetic uses of BOTOX, SEM CUT M S, 20(2), 2001, pp. 121-126
Authors:
Brin, MF
Lyons, KE
Doucette, J
Adler, CH
Caviness, JN
Comella, CL
Dubinsky, RM
Friedman, JH
Manyam, BV
Matsumoto, JY
Pullman, SL
Rajput, AH
Sethi, KD
Tanner, C
Koller, WC
Citation: Mf. Brin et al., A randomized, double masked, controlled trial of botulinum toxin type A inessential hand tremor, NEUROLOGY, 56(11), 2001, pp. 1523-1528
Authors:
Velickovic, M
Benabou, R
Brin, MF
Citation: M. Velickovic et al., Cervical dystonia - Pathophysiology and treatment options, DRUGS, 61(13), 2001, pp. 1921-1943
Authors:
Walker, RH
Brin, MF
Sandu, D
Gujjari, P
Hof, PR
Olanow, CW
Shashidharan, P
Citation: Rh. Walker et al., Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain, BRAIN RES, 900(2), 2001, pp. 348-354
Authors:
Morrison, CE
Borod, JC
Brin, MF
Raskin, SA
Germano, IM
Weisz, DJ
Olanow, CW
Citation: Ce. Morrison et al., A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: Development, feasibility, and preliminary data, NEUROPS NEU, 13(3), 2000, pp. 204-219
Authors:
Walker, RH
Danisi, FO
Swope, DM
Goodman, RR
Germano, IM
Brin, MF
Citation: Rh. Walker et al., Intrathecal baclofen for dystonia: Benefits and complications during six years of experience, MOVEMENT D, 15(6), 2000, pp. 1242-1247
Authors:
Klein, C
Gurvich, N
Sena-Esteves, M
Bressman, S
Brin, MF
Ebersole, BJ
Fink, S
Forsgren, L
Friedman, J
Grimes, D
Holmgren, G
Kyllerman, M
Lang, AE
de Leon, D
Leung, J
Prioleau, C
Raymond, D
Sanner, G
Saunders-Pullman, R
Vieregge, P
Wahlstrom, J
Breakefield, XO
Kramer, PL
Ozelius, LJ
Sealfon, SC
Citation: C. Klein et al., Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia, ANN NEUROL, 47(3), 2000, pp. 369-373
Authors:
Binder, WJ
Brin, MF
Blitzer, A
Schoenrock, LD
Pogoda, JM
Citation: Wj. Binder et al., Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study, OTO H N SUR, 123(6), 2000, pp. 669-676
Authors:
Olanow, CW
Brin, MF
Obeso, JA
Citation: Cw. Olanow et al., The role of deep brain stimulation as a surgical treatment for Parkinson'sdisease, NEUROLOGY, 55(12), 2000, pp. S60-S66
Authors:
Comella, CL
Jankovic, J
Brin, MF
Citation: Cl. Comella et al., Use of botulinum toxin type A in the treatment of cervical dystonia, NEUROLOGY, 55(12), 2000, pp. S15-S21
Authors:
Bressman, SB
Sabatti, C
Raymond, D
de Leon, D
Klein, C
Kramer, PL
Brin, MF
Fahn, S
Breakefield, X
Ozelius, LJ
Risch, NJ
Citation: Sb. Bressman et al., The DYT1 phenotype and guidelines for diagnostic testing, NEUROLOGY, 54(9), 2000, pp. 1746-1752
Authors:
Shashidharan, P
Good, PF
Hsu, A
Perl, DP
Brin, MF
Olanow, CW
Citation: P. Shashidharan et al., TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease, BRAIN RES, 877(2), 2000, pp. 379-381
Authors:
Shashidharan, P
Kramer, BC
Walker, RH
Olanow, CW
Brin, MF
Citation: P. Shashidharan et al., Immunohistochemical localization and distribution of torsinA in normal human and rat brain, BRAIN RES, 853(2), 2000, pp. 197-206
Authors:
Klein, C
Schilling, K
Saunders-Pullman, RJ
Garrels, J
Breakefield, XO
Brin, MF
deLeon, D
Doheny, D
Fahn, S
Fink, JS
Forsgren, L
Friedman, J
Frucht, S
Harris, J
Holmgren, G
Kis, B
Kurlan, R
Kyllerman, M
Lang, AE
Leung, J
Raymond, D
Robishaw, JD
Sanner, G
Schwinger, E
Tabamo, RE
Tagliati, M
Vieregge, P
Wahlstrom, J
Wendt, KJ
Kramer, PL
Bressman, SB
Ozelius, LJ
Citation: C. Klein et al., A major locus for myoclonus-dystonia maps to chromosome 7q in eight families, AM J HU GEN, 67(5), 2000, pp. 1314-1319
Authors:
Ozelius, LJ
Page, CE
Klein, C
Hewett, JW
Mineta, M
Leung, J
Shalish, C
Bressman, SB
de Leon, D
Brin, MF
Fahn, S
Corey, DP
Breakefield, XO
Citation: Lj. Ozelius et al., The TOR1A (DYT1) gene family and its role in early onset torsion dystonia, GENOMICS, 62(3), 1999, pp. 377-384
Authors:
Mezaki, T
Kaji, R
Brin, MF
Hirota-Katayama, M
Kubori, T
Shimizu, T
Kimura, J
Citation: T. Mezaki et al., Combined use of type A and F botulinum toxins for blepharospasm: A double-blind controlled trial, MOVEMENT D, 14(6), 1999, pp. 1017-1020
Authors:
Walker, RH
Spiera, H
Brin, MF
Olanow, CW
Citation: Rh. Walker et al., Parkinsonism associated with Sjogren's syndrome: Three cases and a review of the literature, MOVEMENT D, 14(2), 1999, pp. 262-268
Authors:
Lazzarini, A
Walters, AS
Hickey, K
Coccagna, G
Lugaresi, E
Ehrenberg, BL
Picchietti, DL
Brin, MF
Stenroos, ES
Verrico, T
Johnson, WG
Citation: A. Lazzarini et al., Studies of penetrance and anticipation in five autosomal-dominant restlesslegs syndrome pedigrees, MOVEMENT D, 14(1), 1999, pp. 111-116
Authors:
Brin, MF
Lew, MF
Adler, CH
Comella, CL
Factor, SA
Jankovic, J
O'Brien, C
Murray, JJ
Wallace, JD
Willmer-Hulme, A
Koller, M
Citation: Mf. Brin et al., Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia, NEUROLOGY, 53(7), 1999, pp. 1431-1438
Authors:
Brashear, A
Lew, MF
Dykstra, DD
Comella, CL
Factor, SA
Rodnitzky, RL
Trosch, R
Singer, C
Brin, MF
Murray, JJ
Wallace, JD
Willmer-Hulme, A
Koller, M
Citation: A. Brashear et al., Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia, NEUROLOGY, 53(7), 1999, pp. 1439-1446
Authors:
Klein, C
Page, CE
LeWitt, P
Gordon, MF
de Leon, D
Awaad, Y
Breakefield, XO
Brin, MF
Ozelius, LJ
Citation: C. Klein et al., Genetic analysis of three patients with an 18p- syndrome and dystonia, NEUROLOGY, 52(3), 1999, pp. 649-651
Authors:
Klein, C
Brin, MF
Kramer, P
Sena-Esteves, M
de Leon, D
Doheny, D
Bressman, S
Fahn, S
Breakefield, XO
Ozelius, LJ
Citation: C. Klein et al., Association of a missense change in the D2 dopamine receptor with myoclonus dystonia, P NAS US, 96(9), 1999, pp. 5173-5176
Risultati:
1-23
|